Norway· NO-ID_045439EE-4680-42B2-8D71-152323737E03
Bimzelx
A bimekizumab product containing bimekizumab, registered in Norway by UCB Pharma S.A. (2). The same ATC class is registered in 14 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Bimekizumab is registered in 14 of 19 countries.
Countries holding a registration under ATC L04AC21 (bimekizumab), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Bimekizumab · ATC L04AC21
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of bimekizumab costs, country by country.
Normalised to the WHO defined daily dose (5.7 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Bimekizumab · price per daily dose (5.7 mg)
USD · FX 28 Sept 2026
- CH Switzerland$43.14
The record
At a glance
FEST (Norway)- Active substance
- Bimekizumab
- Manufacturer
- UCB Pharma S.A. (2)
- Country
- Norway (NO)
- ATC code
- L04AC21
- ATC class
- Bimekizumab
- Defined daily dose
- 5.7 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 5
1 priced- no_merkevare_idID_045439EE-4680-42B2-8D71-152323737E03
- no_varenummer0743501 x 160NOK 12198.1
- gtin5413787224623
- no_varenummer390221
- gtin5413787220229
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bimekizumab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBIMZELXUCB Pharma SA, Brusel
- United KingdomBimzelx 160mg/1ml solution for injection pre-filled pensUCB Pharma Ltd
- IcelandBimzelxUCB Pharma S.A.*
- SwedenBimzelx 160 mg Injektionsvätska, lösning i förfylld injektionspennaUCB Pharma S.A.
- SpainBIMZELX 160 MG SOLUCION INYECTABLE EN JERINGA PRECARGADAUcb Pharma
- BelgiumBimzelx 160 mgUCB Pharma
- PolandBimzelxUCB Pharma S.A.
- SwitzerlandBimzelx
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Bimzelx
- Liechtenstein · Bimzelx
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f2f787e1-45cf-48e7-826e-be894378b0cb GET /v1/drugs/f2f787e1-45cf-48e7-826e-be894378b0cb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, oppløsning i ferdigfylt sprøyte",
"source": "fest",
"status": "A",
"atc_name": "Bimekizumab",
"merkevare_id": "ID_045439EE-4680-42B2-8D71-152323737E03",
"name_form_strength": "Bimzelx inj, oppl 160 mg/sprøyte",
"prescription_group": "C"
}See everything about bimekizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.